Ergoteles’s iShares Biotechnology ETF IBB Stock Holding History

Ergoteles’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$587K	Sell	4,800 -202,212	-98%	-$25.7M	0.86%	14
2023 Q2	$26.3M	Sell	207,012 -8,869	-4%	-$1.15M	1.26%	6
2023 Q1	$27.9M	Sell	215,881 -460,886	-68%	-$60.3M	1.09%	16
2022 Q4	$88.9M	Buy	676,767 +664,092	+5,239%	+$85.8M	3.26%	1
2022 Q3	$1.48M	Sell	12,675 -313,940	-96%	-$39M	0.05%	355
2022 Q2	$38.4M	Buy	326,615 +67,887	+26%	+$8.06M	1.15%	7
2022 Q1	$33.7M	Buy	258,728 +37,755	+17%	+$4.92M	1.28%	9
2021 Q4	$33.7M	Buy	+220,973	New	+$34.2M	1.31%	11
2021 Q3	–	Sell	-606,839	Closed	-$99.3M	–	1416
2021 Q2	$99.3M	Buy	606,839 +502,916	+484%	+$77.5M	2.28%	2
2021 Q1	$15.6M	Buy	103,923 +38,145	+58%	+$6.06M	0.49%	57
2020 Q4	$9.96M	Buy	+65,778	New	+$9.4M	0.33%	79

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ergoteles's IBB Position: Q3 2023 in Review

Ergoteles reduced its iShares Biotechnology ETF (IBB) stake by 98% in Q3 2023, selling an estimated $25.7M and leaving 4,800 shares worth $587K. The position accounts for 0.86% of the portfolio, ranked #14.

Ergoteles first reported a position in IBB in Q4 2020 and has held it in 11 quarters since. The position peaked at $99.3M in Q2 2021. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Ergoteles held 4,800 shares of iShares Biotechnology ETF worth $587K as of Q3 2023.
Ergoteles sold 202,212 iShares Biotechnology ETF shares in Q3 2023, an estimated $25.7M.
iShares Biotechnology ETF made up 0.86% of Ergoteles's portfolio in Q3 2023, its #14 holding.
Ergoteles first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 11 quarters since.
Ergoteles's iShares Biotechnology ETF position peaked at $99.3M in Q2 2021.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.